WHO guidelines for treatment of tuberculosis: the missing links
- 324 Downloads
Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis.
KeywordsAntihistamines Health related quality of life Side effects Sputum induction Treatment outcomes Tuberculosis WHO Guidelines
Authors would like to thank Institute of Postgraduate Studies (IPS) at University Sains Malaysia for their financial support in carrying out this work through USM-RU-PRGS (1001/PFARMASI/844011).
Conflicts of interest
- 1.World Health Organization. Treatment of Tuberculosis Guidelines; 2009. Report No.: WHO/HTM/TB/2009/420. ISBN: 9789241547833.Google Scholar
- 2.World Health Organization. Preamble to the constitution of the World Health Organization as adopted by the International Health Conference. International Health Conference; New York. 1946 [cited 1 May 2012]; Available from: http://whqlibdoc.who.int/hist/official_records/constitution.pdf.
- 3.Spilker B. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Philadelphia; 1996. ISBN: 0781703328.Google Scholar
- 18.Gonzalez-Angulo Y, Wiysonge CS, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, Hatherill M. Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2011 [Epub ahead of print]. Available from: http://www.springerlink.com/content/er6674p5785711rg/.
- 19.Crofton J, Horne NW, Miller F. Clinical tuberculosis. London: The Macmillan Education Limited; 2008. ISBN: 140509737X.Google Scholar
- 20.Atif M, Sulaiman SAS, Shafie AA, Muttalif AR, Ali I, Saleem F. Applying patient centered approach in management of pulmonary tuberculosis: a case report from Malaysia. J Basic Clin Pharm. 2011;2(3):129–31.Google Scholar
- 21.Mason J, Reynolds R, Rao N. The systemic safety of fexofenadine HCl. Clin Exp Allergy. 1999;29(S3):163–70.Google Scholar